Preclinical Services from Hit to IND.

Six core capabilities, one team. Run end to end by our scientists.

Disease Models

Disease Models

Validated preclinical models across inflammation, metabolic, CNS, and oncology indications.

Validated preclinical models across inflammation, metabolic, CNS, and oncology indications.

In Vitro Assays

Cell-based and biochemical assays including cytokine profiling, apoptosis, cytotoxicity, and BSL-2 infection work.

Pharmacokinetics

Pharmacokinetics

Single-dose, multi-dose, and formulation comparison studies in rodent and non-rodent species, with organ distribution.

Single-dose, multi-dose, and formulation comparison studies in rodent and non-rodent species, with organ distribution.

Medicinal Chemistry

Medicinal Chemistry

Hit-to-lead and lead optimization with integrated SAR design, custom synthesis, and IP strategy.

Hit-to-lead and lead optimization with integrated SAR design, custom synthesis, and IP strategy.

Cytometry & Histology

Cytometry & Histology

Multiplex flow cytometry, IHC, and quantitative digital pathology for tissue and immune characterization.

LCMS/MS Analytics

LCMS/MS Analytics

Triple-quad bioanalytics for PK, biomarker quantification, and exposure studies across plasma and tissue matrices.

Triple-quad bioanalytics for PK, biomarker quantification, and exposure studies across plasma and tissue matrices.

Specialized Laboratory Capabilities

Our S1/S2/S3 facilities offer high-containment biosafety, supporting advanced research in infectious disease, toxicology and regulated studies. Imaging and ultrasound, cognitive and CNS studies further expand our translational suite.

We deliver comprehensive, regulatory-compliant services in toxicology, imaging, behavioral studies, and advanced analytics. Our experienced team ensures quality data to drive your drug discovery forward.